Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 2/20 | 0.44 |
| ▸ | GRM8 | O00222 | 1/20 | 0.44 |
| ▸ | GRM6 | O15303 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.44 |
| ▸ | GRM5 | P41594 | 1/20 | 0.44 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.44 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.44 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.44 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.44 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL137711 | 0.86 | NOD1 (0.44) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL338792 | 0.82 | SLC1A1 (0.58) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL562202 | 0.82 | SLC1A1 (0.58) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL6146852 | 0.82 | SLC1A1 (0.58) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL210492 | 0.81 | GRM8 (0.63) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL29240006 | 0.81 | GRM8 (0.63) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL15420878 | 0.81 | GRM8 (0.63) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL3174569 | 0.81 | SLC1A1 (0.56) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL7445184 | 0.81 | SLC1A1 (0.56) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL27805447 | 0.81 | SLC1A1 (0.56) | SLC1A1GRM8GRM6GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-1026516-A | — | — | None | — | — | JP | disclosed |
| US-20080182803-A1 | extract from Cassia or Senna plants comprises rubrofusarin gentiobioside with egg white, egg membrane, milk whey, yeast/vegetable proteins, soy bean, L-cysteine, L-methionine, and vitamin C; synergistic; intracellular biosynthesis of glutathione stimulator; liver, brain, vision, or immune disorders | SUNTORY LIMITED | 2008-07-31 | — | — | US | disclosed |
| US-20060110474-A1 | Rubrofusarin glycoside-containing composition | SUNTORY LIMITED (JP) | 2006-05-25 | — | — | US | disclosed |
| EP-1552838-A1 | RUBROFUSARIN GLYCOSIDE-CONTAINING COMPOSITION | SUNTORY LIMITED (JP) | 2005-07-13 | — | — | EP | disclosed |
| US-5624955-A | Compounds that enhance the concentration of glutathione in tissues | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1997-04-29 | — | — | US | disclosed |
| EP-0276317-B1 | GAMMA-L-GLUTAMYL-L-CYSTEINE ETHYL ESTER AND DRUG CONTAINING IT AS EFFECTIVE INGREDIENT | TEIJIN LIMITED (JP) | 1993-03-17 | — | — | EP | disclosed |
| US-4927808-A | GLUTATHIONE LEVELS IN TISSUES | TEIJIN LIMITED (JP) | 1990-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060110474-A1 | Rubrofusarin glycoside-containing composition | GSTP1, GLS, MGST3 | SLC1A1 821/4885GRM8 1157/4885GRM6 718/4885 |
| US-20080182803-A1 | extract from Cassia or Senna plants comprises rubrofusarin gentiobioside with egg white, egg membrane, milk whey, yeast/vegetable proteins, soy bean, L-cysteine, L-methionine, and vitamin C; synergistic; intracellular biosynthesis of glutathione stimulator; liver, brain, vision, or immune disorders | GSS, GSTP1, GSTM2 | SLC1A1 1988/4885GRM8 1436/4885GRM6 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.